Profil
George Garibaldi is the founder of Noema Pharma AG.
Currently, Dr. Garibaldi holds the positions of Director at Retrotope, Inc., Director at MedDay Pharmaceuticals SA, Independent Non-Executive Director at Newron Pharmaceuticals SpA starting in 2026, and Chief Medical Officer at Synendos Therapeutics AG.
Dr. Garibaldi completed graduate studies at the University of Cairo.
Postes actifs de George Garibaldi
| Sociétés | Poste | Début |
|---|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Directeur/Membre du Conseil | 23/04/2026 |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Directeur/Membre du Conseil | - |
Retrotope, Inc.
Retrotope, Inc. BiotechnologyHealth Technology Develops pipeline of proprietary therapeutics | Directeur/Membre du Conseil | - |
Synendos Therapeutics AG
Synendos Therapeutics AG BiotechnologyHealth Technology Operates as a clinical stage and neuroscience company which develops therapies for neuropsychiatric disorders | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de George Garibaldi
| Sociétés | Poste | Fin |
|---|---|---|
Noema Pharma AG
Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system | Fondateur | - |
Formation de George Garibaldi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Newron Pharmaceuticals SpA
Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
University of Cairo
University of Cairo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Retrotope, Inc.
Retrotope, Inc. BiotechnologyHealth Technology Develops pipeline of proprietary therapeutics | Health Technology |
MedDay Pharmaceuticals SAS
MedDay Pharmaceuticals SAS BiotechnologyHealth Technology Operates as a biotechnology company developing new drugs for nervous system disorders | Health Technology |
Synendos Therapeutics AG
Synendos Therapeutics AG BiotechnologyHealth Technology Operates as a clinical stage and neuroscience company which develops therapies for neuropsychiatric disorders | Health Technology |
Noema Pharma AG
Noema Pharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotech company that provide therapeutics for central nervous system | Commercial Services |
















